Income statement
CAD
Annual
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
| Revenue | 2M | 121K | 0 | 0 | 0 |
| Gross Profit | -3M | -184K | -34K | 0 | 0 |
| Operating Income | -5M | -1M | -692K | -6M | -5M |
| EBITDA | -5M | -1M | -658K | -6M | -5M |
| Net Income | -5M | -8M | -2M | -5M | -4M |
| EPS (Diluted) | — | — | — | — | — |
Healthcare
Live Price
Offline$0.0035
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 12, 2026
Coverage: 245 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
West Island Brands Inc. (WIBFF) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of +1815.8%, EPS growth of +39.2%, a dividend yield of 0.0%. What stands out right now is revenue +1815.8%, EPS +39.2%, free cash flow -21.3% with operating margin -217.5% and ROIC -101.6%. Valuation is more restrained than many high-expectation growth names at price/sales 1.0. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines WIBFF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
WIBFF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
WIBFF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for WIBFF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
FY Net Income
-$3.9M
+25.8% YoY
Free Cash Flow
-$223.3K
+70.5% YoY
Revenue Growth
+1815.8%
EPS Growth
+39.2%
Gross Margin
-113.0%
Net Margin
-228.7%
Income statement
CAD
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
| Revenue | 2M | 121K | 0 | 0 | 0 |
| Gross Profit | -3M | -184K | -34K | 0 | 0 |
| Operating Income | -5M | -1M | -692K | -6M | -5M |
| EBITDA | -5M | -1M | -658K | -6M | -5M |
| Net Income | -5M | -8M | -2M | -5M | -4M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
CAD
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
| Cash & Equivalents | 204K | 1M | 2M | 5M | 4M |
| Total Assets | 6M | 9M | 15M | 15M | 9M |
| Total Liabilities | 3M | 2M | 283K | 283K | 229K |
| Shareholder Equity | 3M | 7M | 15M | 14M | 8M |
| Total Debt | 2M | 1M | 191K | 0 | 0 |
| Net Debt | 2M | 224K | -1M | -5M | -4M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
223K
+70.5% YoY
Capital Expenditures
0
Free Cash Flow
223K
+70.5% YoY
Key ratios
Gross Margin
-113.0%
Operating Margin
-217.5%
Net Margin
-228.7%
ROE
-99.7%
Debt / Equity
0.52x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.